View More Recent Stories

May 13, 2025 07:43AM Xenon Pharmaceuticals (XENE) Tops Q1 EPS by 8c
May 13, 2025 07:29AM Xenon Pharmaceuticals (XENE) PT Lowered to $55 at Needham
May 7, 2025 04:30AM Chardan Capital Markets Starts Xenon Pharmaceuticals (XENE) at Buy
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more
Feb 27, 2025 04:19PM Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 1c
Feb 11, 2025 04:17AM Deutsche Bank Starts Xenon Pharmaceuticals (XENE) at Buy
Jan 13, 2025 08:33AM Xenon Pharmaceuticals (XENE) Outlines Key Corporate Milestone Opportunities for 2025
Jan 6, 2025 10:35AM TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
Dec 21, 2024 10:00AM RBC report: Biotech faces both uncertainty and growth opportunities in 2025
Dec 12, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Xenon Pharmaceuticals (XENE)
Dec 6, 2024 04:01PM Xenon Pharmaceuticals (XENE) Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
Nov 30, 2024 10:00PM JPMorgan is out with its 2025 outlook for biotech stocks
Nov 13, 2024 06:58AM H.C. Wainwright Reiterates Buy Rating on Xenon Pharmaceuticals (XENE)
Nov 13, 2024 06:48AM Xenon Pharmaceuticals (XENE) PT Raised to $56 at RBC Capital
Nov 12, 2024 04:16PM Xenon Pharmaceuticals (XENE) Tops Q3 EPS by 1c
Oct 10, 2024 08:24AM Raymond James Resumes Xenon Pharmaceuticals (XENE) at Outperform
Oct 1, 2024 06:04AM H.C. Wainwright Starts Xenon Pharmaceuticals (XENE) at Buy
Aug 12, 2024 08:36AM Xenon Pharmaceuticals (XENE) Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as COO
Aug 9, 2024 05:00PM Xenon Pharmaceuticals (XENE) Files Mixed Shelf
Aug 8, 2024 04:54PM Xenon Pharmaceuticals (XENE) Misses Q2 EPS by 5c
Jun 18, 2024 06:20AM RBC Capital Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE)
View More Recent Stories